The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity

Toxicology Letters

Volumn 154, Issue 1-2, 2004, Pages 117-123

  Maňáková, Šárka ^a   Puttonen, Katja A ^a   Raasmaja, Atso ^b   Männistö, Pekka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Apoptosis; Bcl 2 protein; GBR 12909; p53 protein; Reactive oxygen species

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; DOPAMINE TRANSPORTER; OXIDOPAMINE; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; VANOXERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN PROTECTION; CELL HYBRIDIZATION; CELL PROTECTION; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; NEUROPATHOLOGY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ADRENERGIC AGENTS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBROBLASTS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; OXIDOPAMINE; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; CERCOPITHECUS AETHIOPS;

EID: 4744351495     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.07.007     Document Type: Article

References (35)

1. 2 in chromaffin cells Eur. J. Pharmacol. 293 1995 55 64
2. D. Blum, S. Torch, M.F. Nissou, A.L. Benabid, and J.M. Verna Extracellular toxicity of 6-hydroxydopamine on PC12 cells Neurosci. Lett. 283 2000 193 196
3. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease: a review Prog. Neurobiol. 65 2001 135 172
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. J.L. Cadet Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice: a review Parkinsonism Relat. Disord. 8 2001 85 90
6. Y.M. Chung, Y.S. Bae, and S.Y. Lee Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis Free Radic. Biol. Med. 34 2003 434 442
7. G. Cohen, and R.E. Heikkila The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents J. Biol. Chem. 249 1974 2447 2452
8. R.C. Dodel, Y. Du, K.R. Bales, Z. Ling, P.M. Carvey, and S.M. Paul Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res. Mol. Brain Res. 64 1999 141 148
9. T. Enoch, and C. Norbury Cellular responces to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM Trends Biochem. Sci. 20 1995 426 430
10. D.M. Frim, M.P. Short, W.S. Rosenberg, J. Simpson, X.O. Breakefield, and O. Isacson Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum J. Neurosurg. 78 1993 267 273
11. Y. Glinka, M. Gassen, and M.B. Youdim Mechanism of 6-hydroxydopamine neurotoxicity: a review J. Neural Transm. Suppl. 50 1997 55 66
12. D.G. Graham, S.M. Tiffany, W.R. Bell Jr., and W.F. Gutknecht Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Mol. Pharmacol. 14 1978 644 653
13. R. Heikkila, and G. Cohen Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid Mol. Pharmacol. 8 1972 241 248
14. Z. Hyvönen, M. Ruponen, S. Rönkkö, P. Suhonen, and A. Urtti Extracellular and intracellular factors influencing gene transfectionmediated by 1,4-dihydropyridine amphiphiles Eur. J. Pharm. Sci. 15 2002 449 460
15. G. Jonsson, and C. Sachs Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons Eur. J. Pharmacol. 9 1970 141 155
16. P. Lampela, J. Räisänen, P.T. Männistö, S. Ylä-Herttuala, and A. Raasmaja The use of low-molecular-weight PEIs as gene carriers in the monkey fibroblastoma and rabbit smooth muscle cell cultures J. Gene Med. 4 2002 205 214
17. A.J. Levine p53, the cellular gatekeeper for growth and division: a review Cell 88 1997 323 331
18. Š. Maňáková, K.A. Puttonen, A. Raasmaja, and P.T. Männistö Ara-C induces apoptosis in monkey fibroblast cells Toxicol. In Vitro 17 2003 367 373
19. J.C. Mayo, R.M. Sainz, I. Antolin, and C. Rodriguez Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res. 818 1999 221 227
20. N. Nakachi, Y. Kiuchi, M. Inagaki, M. Inazu, Y. Yamazaki, and K. Oguchi Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats Eur. J. Pharmacol. 281 1995 195 203
21. E. Perez-Navarro, A.M. Canudas, P. Akerund, J. Alberch, and E. Arenas Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease J. Neurochem. 75 2000 2190 2199
22. K.A. Puttonen, Š. Maňáková, A. Raasmaja, and P.T. Männistö Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells Cell Biol. Toxicol. 19 2003 177 187
23. A. Saner, and H. Thoenen Model experiments on the molecular mechanism of action of 6-hydroxydopamine Mol. Pharmacol. 7 1971 147 154
24. T.A. Sarafian, L. Vartavarian, D.J. Kane, D.E. Bredesen, and M.A. Verity Bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line Toxicol. Lett. 74 1994 149 155
25. G. Seitz, H.B. Stegmann, H.H. Jager, H.M. Schlude, H. Wolburg, V.A. Roginsky, D. Niethamme, and G. Bruchelt Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine J. Neurochem. 75 2000 511 520
26. C.W. Shults, J. Ray, K. Tsuboi, and F.H. Gage Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine Brain Res. 883 2000 192 204
27. A. Slivka, and G. Cohen Hydroxyl radical attack on dopamine J. Biol. Chem. 260 1985 15466 15472
28. R. Soto-Otero, E. Mendez-Alvarez, A. Hermida-Ameijeiras, A.M. Munoz-Patino, and J.L. Labandeira-Garcia Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease Neurochemistry 74 2000 1605 1612
29. C.W. Tsao, J.T. Cheng, C.L. Shen, and Y.S. Lin 6-Hydroxydopamine induces thymocyte apoptosis in mice J. Neuroimmunol. 65 1996 91 95
30. U. Ungerstedt 6-Hydroxy-dopamine induced degeneration of central monoamine neurons Eur. J. Pharmacol. 5 1968 107 110
31. N.J. Uretsky, and L.L. Iversen Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain J. Neurochem. 17 1970 269 278
32. M.G. Vander Heiden, and C.B. Thompson Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? A review Nat. Cell Biol. 1 1999 E209 E216
33. G. Walkinshaw, and C.M. Waters Neurotoxin-induced cell death in neuronal PC 12 cells is mediated by induction of apoptosis Neuroscience 63 1994 975 987
34. Y. Wang, L. Szekely, I. Okan, G. Klein, and K.G. Wiman Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line Oncogene 8 1993 3427 3431
35. K.C. Zimmermann, C. Bonzon, and D.R. Green The machinery of programmed cell death: a review Pharmacol. Ther. 92 2001 57 70